Enovix Co. (NASDAQ:ENVX - Free Report) - Analysts at Northland Capmk issued their Q1 2026 earnings per share estimates for shares of Enovix in a report issued on Thursday, February 20th. Northland Capmk analyst G. Richard expects that the company will post earnings of ($0.27) per share for the quarter. The consensus estimate for Enovix's current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix's Q2 2026 earnings at ($0.27) EPS, Q3 2026 earnings at ($0.27) EPS and Q4 2026 earnings at ($0.27) EPS.
Enovix (NASDAQ:ENVX - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The company had revenue of $9.72 million for the quarter, compared to analysts' expectations of $8.77 million.
Several other brokerages have also recently weighed in on ENVX. Craig Hallum reduced their price objective on Enovix from $20.00 to $18.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Janney Montgomery Scott downgraded Enovix from a "buy" rating to a "neutral" rating and set a $10.00 target price on the stock. in a research report on Thursday, October 31st. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $30.00 price target on shares of Enovix in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $20.30.
Read Our Latest Report on ENVX
Enovix Price Performance
Shares of Enovix stock traded down $0.12 during trading hours on Monday, reaching $8.92. The company's stock had a trading volume of 7,578,811 shares, compared to its average volume of 7,067,936. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. Enovix has a one year low of $5.70 and a one year high of $18.68. The firm has a 50 day moving average price of $11.24 and a 200-day moving average price of $10.26. The stock has a market cap of $1.59 billion, a P/E ratio of -6.15 and a beta of 1.87.
Institutional Trading of Enovix
A number of large investors have recently modified their holdings of ENVX. Prospera Private Wealth LLC purchased a new stake in shares of Enovix in the 3rd quarter worth $27,000. Fifth Third Bancorp lifted its stake in Enovix by 66.7% in the fourth quarter. Fifth Third Bancorp now owns 2,500 shares of the company's stock worth $27,000 after acquiring an additional 1,000 shares during the period. Coppell Advisory Solutions LLC bought a new position in Enovix during the 4th quarter worth about $27,000. Sava Infond d.o.o. purchased a new position in Enovix during the 4th quarter valued at about $43,000. Finally, Hollencrest Capital Management raised its holdings in shares of Enovix by 61.4% in the 4th quarter. Hollencrest Capital Management now owns 5,256 shares of the company's stock valued at $57,000 after purchasing an additional 2,000 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company's stock.
Insider Activity
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the company's stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total value of $729,750.00. Following the transaction, the director now directly owns 99,497 shares in the company, valued at $968,105.81. This represents a 42.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.70% of the company's stock.
Enovix Company Profile
(
Get Free Report)
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More

Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.